Dezhi Cheng

538 total citations
27 papers, 378 citations indexed

About

Dezhi Cheng is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Dezhi Cheng has authored 27 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Molecular Biology and 8 papers in Cancer Research. Recurrent topics in Dezhi Cheng's work include Lung Cancer Treatments and Mutations (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (3 papers). Dezhi Cheng is often cited by papers focused on Lung Cancer Treatments and Mutations (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (3 papers). Dezhi Cheng collaborates with scholars based in China, Thailand and United States. Dezhi Cheng's co-authors include Zhifeng He, Changzheng Sun, Yi Xu, Deyao Xie, Peng Zhang, Weicong Huang, Xiang Zhang, Shangwen Dong, Yu Liu and Liang Zhao and has published in prestigious journals such as PLoS ONE, The Journal of Physical Chemistry B and Molecular Cancer.

In The Last Decade

Dezhi Cheng

26 papers receiving 372 citations

Peers

Dezhi Cheng
Lixin Yang China
Yangwei Xu China
Zhifeng Han China
Xiaoli Liao China
Neil Oronsky United States
Guojun Geng China
Kefeng Wang China
Yuping Zhu China
Amr S. Saad Egypt
Lixin Yang China
Dezhi Cheng
Citations per year, relative to Dezhi Cheng Dezhi Cheng (= 1×) peers Lixin Yang

Countries citing papers authored by Dezhi Cheng

Since Specialization
Citations

This map shows the geographic impact of Dezhi Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dezhi Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dezhi Cheng more than expected).

Fields of papers citing papers by Dezhi Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dezhi Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dezhi Cheng. The network helps show where Dezhi Cheng may publish in the future.

Co-authorship network of co-authors of Dezhi Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Dezhi Cheng. A scholar is included among the top collaborators of Dezhi Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dezhi Cheng. Dezhi Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Pan, Xiongfeng, et al.. (2024). Theranostic nanoparticles ZIF-8@ICG for pH/NIR-responsive drug-release and NIR-guided chemo-phototherapy against non-small-cell lung cancer. Journal of Materials Science Materials in Medicine. 35(1). 32–32. 8 indexed citations
3.
Cheng, Dezhi, Yao Ai, Jian Wu, et al.. (2024). Multi-omics deep learning for radiation pneumonitis prediction in lung cancer patients underwent volumetric modulated arc therapy. Computer Methods and Programs in Biomedicine. 254. 108295–108295. 9 indexed citations
4.
Liu, Conghui, Ying Bai, Lehe Yang, et al.. (2023). Acetyl-cinobufagin suppresses triple-negative breast cancer progression by inhibiting the STAT3 pathway. Aging. 15(16). 8258–8274. 11 indexed citations
5.
Li, Qun, Xiaoyan Zhang, Jiao Feng, et al.. (2021). Case Report: Next-Generation Sequencing Reveals Tumor Origin in a Female Patient With Brain Metastases. Frontiers in Oncology. 11. 569429–569429. 1 indexed citations
6.
Chen, Kun, Zhihao Yang, Xinbo Zhang, et al.. (2020). Clinical features and prognosis of primary tracheal small cell carcinoma: a population-based analysis. Translational Cancer Research. 9(2). 882–890. 1 indexed citations
7.
Chen, Kun, Zhihao Yang, Dongdong Yu, et al.. (2020). Sites of distant metastases and the cancer-specific survival of metastatic Siewert type II esophagogastric junction adenocarcinoma: a population-based study. Expert Review of Gastroenterology & Hepatology. 14(6). 491–497. 5 indexed citations
8.
Zhang, Xiang, Dezhi Cheng, Yu Liu, Yuanbo Wu, & Zhifeng He. (2019). <p>Gephyrin suppresses lung squamous cell carcinoma development by reducing mTOR pathway activation</p>. Cancer Management and Research. Volume 11. 5333–5341. 4 indexed citations
9.
Li, Wenfeng, Shanshan Yu, Xingchen Wang, et al.. (2019). Tumor shrinkage rate as a potential marker for the prediction of long-term outcome in advanced non-small cell lung cancer treated with first-line tyrosine kinase inhibitors. Journal of Cancer Research and Therapeutics. 15(7). 1574–1574. 1 indexed citations
10.
Chang, Yu, Lehe Yang, Feng Zhou, et al.. (2019). Down‐regulation of MTHFD2 inhibits NSCLC progression by suppressing cycle‐related genes. Journal of Cellular and Molecular Medicine. 24(2). 1568–1577. 31 indexed citations
11.
Cheng, Dezhi, et al.. (2018). LncRNA PRNCR1 interacts with HEY2 to abolish miR-448-mediated growth inhibition in non-small cell lung cancer. Biomedicine & Pharmacotherapy. 107. 1540–1547. 32 indexed citations
12.
Chen, Liping, Jiabing Wang, Yangyang Zhou, et al.. (2018). Design, synthesis, anti-lung cancer activity, and chemosensitization of tumor-selective MCACs based on ROS-mediated JNK pathway activation and NF-κB pathway inhibition. European Journal of Medicinal Chemistry. 151. 508–519. 34 indexed citations
13.
Zhang, Xiang, Lei Wang, Yu Liu, Weicong Huang, & Dezhi Cheng. (2018). MiR-760 enhances TRAIL sensitivity in non-small cell lung cancer via targeting the protein FOXA1. Biomedicine & Pharmacotherapy. 99. 523–529. 22 indexed citations
14.
15.
Cheng, Dezhi, et al.. (2017). Surgical resection of pulmonary metastases from colorectal cancer: 11 years of experiences. PLoS ONE. 12(4). e0175284–e0175284. 12 indexed citations
16.
Cheng, Dezhi, Yi Xu, Changzheng Sun, & Zhifeng He. (2016). MicroRNA-451 sensitizes lung cancer cells to cisplatin through regulation of Mcl-1. Molecular and Cellular Biochemistry. 423(1-2). 85–91. 35 indexed citations
17.
He, Zhifeng, Changzheng Sun, Yi Xu, & Dezhi Cheng. (2016). Reduction of atrial fibrillation by Tanshinone IIA in chronic heart failure. Biomedicine & Pharmacotherapy. 84. 1760–1767. 16 indexed citations
18.
Li, Wenfeng, Weiwei Yin, Rongying Ou, et al.. (2015). The value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in asymptomatic examinees with unexplained elevated blood carcinoembryonic antigen levels. European Journal of Nuclear Medicine and Molecular Imaging. 43(4). 675–681. 1 indexed citations
19.
Zhao, Liang, Tong Li, Jie Lin, et al.. (2015). Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis. European Radiology. 25(7). 1837–1844. 16 indexed citations
20.
Cheng, Dezhi, Liang Zhao, Yunsheng Xu, et al.. (2015). K-Ras promotes the non-small lung cancer cells survival by cooperating with sirtuin 1 and p27 under ROS stimulation. Tumor Biology. 36(9). 7221–7232. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lixin Yang Breakdown of academic impact, for papers by Yangwei Xu Breakdown of academic impact, for papers by Zhifeng Han Breakdown of academic impact, for papers by Xiaoli Liao Breakdown of academic impact, for papers by Neil Oronsky Breakdown of academic impact, for papers by Guojun Geng Breakdown of academic impact, for papers by Kefeng Wang Breakdown of academic impact, for papers by Yuping Zhu Breakdown of academic impact, for papers by Amr S. Saad
Rankless by CCL
2026